pmc logo image
Logo of jcinvestCurrent issueArchiveSubscribe to the JCIAbout the JCIThe Journal of Clinical Investigation

Formats:

J Clin Invest. 1972 December; 51(12): 3182–3192.
doi: 10.1172/JCI107145.
PMCID: PMC333000
An Analysis of Lipoproteins, Bile Acids, and Red Cell Membranes Associated with Target Cells and Spur Cells in Patients with Liver Disease
Richard A. Cooper, Milagros Diloy-Puray, Patricia Lando, and Mortimer S. Greenberg
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104
Thorndike Memorial Laboratory, Boston City Hospital, Boston 02118
Lemuel Shattuck Hospital, Boston, Massachusetts 02130
Abstract
Most patients with stable cirrhosis of the alcoholic have “target” red cells; however, a minority have “spur” cells and severe hemolytic anemia. These two syndromes were studied in 27 patients with target cells and 17 patients with spur cells, all of whom had advanced cirrhosis. The cholesterol and phospholipid content of red cell membranes effectively distinguished target cells from spur cells. Target cells alone were rich in lecithin, and both the cholesterol/phospholipid and cholesterol/lecithin mole ratios were greater in spur cells. The cholesterol/phospholipid mole ratio of both types of red cells correlated closely with the free cholesterol saturation of serum lipoproteins, as defined by the amount of free cholesterol relative to phospholipid and protein in these lipoproteins. Lecithin: cholesterol acyltransferase (LCAT) activity was decreased in most patients with target cells and spur cells; however, the relationship between this activity and the lipid abnormalities observed was weak. Serum bile acid levels also correlated poorly with serum and cell lipids. However, in patients with target cells the amount of cholic and deoxycholic acids in serum was approximately equal to the amount of chenodeoxycholic acid, whereas in patients with spur cells chenodeoxycholic acid (the precursor of lithocholic acid) predominated.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • JANDL JH, LEAR AA. The metabolism of folic acid in cirrhosis. Ann Intern Med. 1956 Dec;45(6):1027–1044. [PubMed]
  • HERBERT V, ZALUSKY R, DAVIDSON CS. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver disease. Ann Intern Med. 1963 Jun;58:977–988. [PubMed]
  • SULLIVAN LW, HERBERT V. SUPPRESSION HEMATOPOIESIS BY ETHANOL. J Clin Invest. 1964 Nov;43:2048–2062. [PubMed]
  • KIMBER C, DELLER DJ, IBBOTSON RN, LANDER H. THE MECHANISM OF ANAEMIA IN CHRONIC LIVER DISEASE. Q J Med. 1965 Jan;34:33–64. [PubMed]
  • Eichner ER, Hillman RS. The evolution of anemia in alcoholic patients. Am J Med. 1971 Feb;50(2):218–232. [PubMed]
  • Kilbridge TM, Heller P. Determinants of erythrocyte size in chronic liver disease. Blood. 1969 Dec;34(6):739–746. [PubMed]
  • JANDL JH. The anemia of liver disease: observations on its mechanism. J Clin Invest. 1955 Mar;34(3):390–404. [PubMed]
  • SMITH JA, LONERGAN ET, STERLING K. SPUR-CELL ANEMIA: HEMOLYTIC ANEMIA WITH RED CELLS RESEMBLING ACANTHOCYTES IN ALCOHOLIC CIRRHOSIS. N Engl J Med. 1964 Aug 20;271:396–398. [PubMed]
  • Silber R, Amorosi E, Lhowe J, Kayden HJ. Spur-shaped erythrocytes in Laennec's cirrhosis. N Engl J Med. 1966 Sep 22;275(12):639–643. [PubMed]
  • Cooper RA. Anemia with spur cells: a red cell defect acquired in serum and modified in the circulation. J Clin Invest. 1969 Oct;48(10):1820–1831. [PubMed]
  • Cooper RA, Jandl JH. Bile salts and cholesterol in the pathogenesis of target cells in obstructive jaundice. J Clin Invest. 1968 Apr;47(4):809–822. [PubMed]
  • Nye WH, Marinetti GV. Alterations in erythrocyte phospholipids produced by environmental change. Proc Soc Exp Biol Med. 1967 Aug–Sep;125(4):1220–1224. [PubMed]
  • Neerhout RC. Abnormalities of erythrocyte stromal lipids in hepatic disease. J Lab Clin Med. 1968 Mar;71(3):438–447. [PubMed]
  • HAGERMAN JS, GOULD RG. The in vitro interchange of cholesterol between plasma and red cells. Proc Soc Exp Biol Med. 1951 Oct;78(1):329–332. [PubMed]
  • Reed CF. Phospholipid exchange between plasma and erythrocytes in man and the dog. J Clin Invest. 1968 Apr;47(4):749–760. [PubMed]
  • Switzer S. Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction. J Clin Invest. 1967 Nov;46(11):1855–1866. [PubMed]
  • Papadopoulos NM, Charles MA. Serum lipoprotein patterns in liver disease. Proc Soc Exp Biol Med. 1970 Jul;134(3):797–799. [PubMed]
  • Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed]
  • Gjone E, Torsvik H, Norum KR. Familial plasma cholesterol ester deficiency. A study of the erythrocytes. Scand J Clin Lab Invest. 1968;21(4):327–332. [PubMed]
  • TURNER KB, McCORMACK GH, Jr, RICHARDS A. The cholesterol-esterifying enzyme of human serum. I. In liver disease. J Clin Invest. 1953 Sep;32(9):801–806. [PubMed]
  • Gjone E, Norum KR. Plasma lecithin-cholesterol acyltransferase and erythrocyte lipids in liver disease. Acta Med Scand. 1970 Mar 3;187(3):153–161. [PubMed]
  • Simon JB, Scheig R. Serum cholesterol esterification in liver disease. N Engl J Med. 1970 Oct 15;283(16):841–846. [PubMed]
  • Cooper RA, Garcia FA, Trey CX. The effect of lithocholic acid on red cell membranes in vivo. J Lab Clin Med. 1972 Jan;79(1):7–18. [PubMed]
  • RUDMAN D, KENDALL FE. Bile acid content of human serum. I. Serum bile acids in patients with hepatic disease. J Clin Invest. 1957 Apr;36(4):530–537. [PubMed]
  • Makino I, Nakagawa S, Mashimo K. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases. Gastroenterology. 1969 Jun;56(6):1033–1039. [PubMed]
  • ROSE HG, OKLANDER M. IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES. J Lipid Res. 1965 Jul;6:428–431. [PubMed]
  • ZLATKIS A, ZAK B, BOYLE AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 1953 Mar;41(3):486–492. [PubMed]
  • BARTLETT GR. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed]
  • Skipski VP, Peterson RF, Barclay M. Quantitative analysis of phospholipids by thin-layer chromatography. Biochem J. 1964 Feb;90(2):374–378. [PubMed]
  • Dodge JT, Cohen G, Kayden HJ, Phillips GB. Peroxidative hemolysis of red blood cells from patients with abetalipoproteinemia (acanthocytosis). J Clin Invest. 1967 Mar;46(3):357–368. [PubMed]
  • HAVEL RJ, EDER HA, BRAGDON JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Margolis S, Langdon RG. Studies on human serum beta-1-lipoprotein. I. Amino acid composition. J Biol Chem. 1966 Jan 25;241(2):469–476. [PubMed]
  • Cooper RA, Gulbrandsen CL. The relationship between serum lipoproteins and red cell membranes in abetalipoproteinemia: deficiency of lecithin:cholesterol acyltransferase. J Lab Clin Med. 1971 Sep;78(3):323–335. [PubMed]
  • GRUNDY SM, AHRENS EH, Jr, MIETTINEN TA. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. J Lipid Res. 1965 Jul;6:397–410. [PubMed]
  • Nair PP, Garcia C. A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids. Anal Biochem. 1969 Apr 11;29(1):164–166. [PubMed]
  • Switzer S. Plasma lipoproteins in the differential diagnosis of liver disease. Gastroenterology. 1967 Nov;53(5):790–793. [PubMed]
  • Cooper RA, Jandl JH. Red cell cholesterol content: a manifestation of the serum affinity for free cholesterol. Trans Assoc Am Physicians. 1969;82:324–330. [PubMed]
  • Calandra S, Martin MJ, McIntyre N. Plasma lecithin: cholesterol acyltransferase activity in liver disease. Eur J Clin Invest. 1971 May;1(5):352–360. [PubMed]
  • Werre JM, Helleman PW, Verloop MC, De Gier J. Causes of macroplania of erythrocytes in diseases of the liver and biliary tract with special reference to leptocytosis. Br J Haematol. 1970 Aug;19(2):223–235. [PubMed]
  • Quarfordt SH, Hilderman HL. Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. J Lipid Res. 1970 Nov;11(6):528–535. [PubMed]
  • Simon JB. Red cell lipids in liver disease: relationship to serum lipids and to lecithin-cholesterol acyltransferase. J Lab Clin Med. 1971 Jun;77(6):891–900. [PubMed]
  • PHILLIPS GB. The lipid composition of serum in patients with liver disease. J Clin Invest. 1960 Nov;39:1639–1650. [PubMed]
  • Kunz F, Kosin D. Plasma phospholipids in cirrhosis of liver and fatty liver. Clin Chim Acta. 1970 Jan;27(1):185–196. [PubMed]
  • Gjone E, Orning OM. Plasma phospholipids in patients with liver disease. A quantitative thin layer chromatographic study. Scand J Clin Lab Invest. 1966;18(2):209–216. [PubMed]
  • Shohet SB, Nathan DG. Incorporation of phosphatide precursors from serum into erythrocytes. Biochim Biophys Acta. 1970 Feb 10;202(1):202–205. [PubMed]
  • Shohet SB. Release of phospholipid fatty acid from human erythrocytes. J Clin Invest. 1970 Sep;49(9):1668–1678. [PubMed]
  • Cooper RA, Jandl JH. The selective and conjoint loss of red cell lipids. J Clin Invest. 1969 May;48(5):906–914. [PubMed]
  • Sha'afi RI, Gary-Bobo C, Solomon AK. Cholesterol effect on hydraulic conductivity of red cell membranes. Biochim Biophys Acta. 1969 Jan 28;173(1):141–142. [PubMed]
  • Cooper RA, Jandl JH. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest. 1969 Apr;48(4):736–744. [PubMed]
  • Torsvik H. Presence of (alpha)-1-lipoprotein in patients with familial plasma lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest. 1969 Sep;24(2):187–196. [PubMed]
  • Hamnström B, Gjone E, Norum KR. Familial plasma lecithin: cholesterol acyltransferase deficiency. Br Med J. 1969 May 3;2(5652):283–286. [PubMed]
  • Norum KR, Borsting S, Grundt I. Familial lecithin: cholesterol acyltransferase deficiency. Study of two new patients and their close relatives. Acta Med Scand. 1970 Oct;188(4):323–326. [PubMed]
  • SANDBERG DH, SJOEVALL J, SJOEVALL K, TURNER DA. MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY. J Lipid Res. 1965 Apr;6:182–192. [PubMed]
  • Carey JB, Jr, Wilson ID, Zaki FG, Hanson RF. The metabolism of bile acids with special reference to liver injury. Medicine (Baltimore). 1966 Nov;45(6):461–470. [PubMed]
  • Jones DP, Sosa FR, Shartsis J, Shah PT, Skromak E, Beher WT. Serum cholesterol esterifying and cholesteryl ester hydrolyzing activities in liver diseases: relationships to cholesterol, bilirubin, and bile salt concentrations. J Clin Invest. 1971 Feb;50(2):259–265. [PubMed]
  • Weis HJ, Dietschy JM. Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback. J Clin Invest. 1969 Dec;48(12):2398–2408. [PubMed]
  • Balint JA, Beeler DA, Kyriakides EC, Treble DH. The effect of bile salts upon lecithin synthesis. J Lab Clin Med. 1971 Jan;77(1):122–133. [PubMed]
  • CAREY JB., Jr The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease. J Clin Invest. 1958 Nov;37(11):1494–1503. [PubMed]
  • HUNT RD, LEVEILLE GA, SAUBERLICH HE. Dietary bile acids and lipid metabolism. II. The ductular cell reaction induced by lithocholic acid. Proc Soc Exp Biol Med. 1963 May;113:139–142. [PubMed]
  • KAPPAS A, PALMER RH. Selected aspects of steroid pharmacology. Pharmacol Rev. 1963 Mar;15:123–167. [PubMed]
  • Carey JB, Jr, Williams G. Lithocholic acid in human-blood serum. Science. 1965 Oct 29;150(696):620–622. [PubMed]